Using HLA-matched related donor (MRD) transplants, Rezvani et al. [13] demonstrated that a high CD4+CD25+FoxP3+ T cell count in the donor graft was associated with a reduced risk of GvHD. The gene discussed is FOXP3; the disease is graft versus host disease.